Notice of Special Interest (NOSI): Research Project Grants in Valvular Heart Disease (CAROL Act)
https://grants.nih.gov/grants/guide/notice-files/NOT-HL-23-079.html
march 7, 2023not-hl-23-085 - nhlbi notice of availability of frequently asked questions (faqs) for not-hl-23-078 and not-hl-23-079 (carol act).pa-20-183 - research project grant (parent r01 clinical trial required)pa-20-185 - nih research project grant (parent r01 clinical trial not allowed)national heart, lung, and blood institute (nhlbi)as part of the national heart, lung, and blood institute’s implementation of the cardiovascular advances in research and opportunities legacy (carol) act, this notice of special interest is seeking r01 applications that propose research in valvular heart disease.selected research examplesthe carol act explicitly encourages research using advanced imaging techniques and research on risk factors for sudden cardiac arrest or sudden cardiac death from valvular heart disease, most commonly associated with mitral valve prolapse (mvp). however, the act also encourages research on valvular heart disease more broadly. selected research examples may include, but are not limited to:these and other research examples are detailed in the report of the nhlbi workshop on research in the treatment of mitral valve prolapse, november 30 – december 2, 2021. applications that propose research on other anatomic valves (e.g., lymphatic valves, venous valves) will not be considered in response to this notice.application and submission informationthis notice applies to due dates on or after june 5, 2023, and subsequent receipt dates through may 7, 2026.applications for this initiative must be submitted using one of the following notices of funding opportunity (nofos, formerly called funding opportunity announcements or foas) or their subsequent reissued equivalents:note: the nhlbi will only accept applications to pa-20-183 - research project grant (parent r01 clinical trial required) that propose mechanistic studies which meet the nih's definition of a clinical trial and that have the primary goal of understanding how an intervention works per guidance in not-hl-19-690. applicants are strongly encouraged to consult the contact listed below prior to submission to confirm that the proposed clinical trial application meets these requirements.all instructions in the sf424 (r&r) application guide and the nofo used for submission must be followed, with the following addition:applications nonresponsive to terms of this nosi will not be considered for the nosi initiative.scientific/research contact(s)frank evans, phdnational heart, lung, and blood institute (nhlbi)telephone: 301-435-0510email: evansf@nhlbi.nih.govpeer review contact(s)examine your era commons account for review assignment and contact information (information appears two weeks after the submission due date).financial/grants management contact(s)francesca hunternational heart, lung, and blood institute (nhlbi)telephone: 301-402-3127email: francesca.hunter@nih.govweekly toc for this announcement nih funding opportunities and noticesnote: for help accessing pdf, rtf, ms word, excel, powerpoint, audio or video files, see help downloading files.